Author | Stella Flampouri, PhD


Improving the Therapeutic Ratio in Hodgkin Lymphoma Through the Use of Proton Therapy

May 15, 2012

ByBradford S. Hoppe, MD, MPH|Stella Flampouri, PhD|James Lynch, MD|William Slayton, MD|Robert Zaiden, MD|Nancy Price Mendenhall, MD

This review addresses the rationale and evidence for-and the challenges, cost implications, and future development of-proton therapy as an important part of the treatment strategy in Hodgkin lymphoma.